A US judge on Monday dismissed a challenge from Bristol Myers Squibb (Bristol Myers Squibb) and Johnson & Johnson against a law requiring the two companies to negotiate with the US government's Medicare plan (Medicare) about the price of their blockbuster products to prevent blood clots; otherwise, they will face heavy penalties. U.S. District Judge Zahid Qulesh of Trenton, New Jersey, became the fourth federal judge to back the plan. The plan is one of the landmark moves against the pharmaceutical industry's challenges, and he dismisses claims that the pharmaceutical industry believes it is an illegal seizure of their property.
强生、百时美施贵宝在美国药品价格谈判程序中败诉
Johnson & Johnson, Bristol-Myers Squibb lose lawsuit in US drug price negotiation process
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.